Fagron
Update in progressFAGR.BR (Brussels)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Fagron NV is a pharmaceutical compounding company delivering personalized care to hospitals, pharmacies, clinics, patients and worldwide. It operates in Essentials, Brands and Compounding Services. Its products include DiluCap and DiluTab excipients, Imuno TF Complex, Pigmerise, Nourisil MD, SyrSpend SF, Pentravan, Cleoderm and Neogen, plus dermatology and hair care lines like Fagron Advanced Derma and TrichoConcept. It offers education via Fagron Academy. Formerly Arseus NV, renamed 2015; founded 1990; based in Nazareth, Belgium.
Company score
- Sentiment
- 0.33
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.23
- Governance
- 0.08
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.09
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.21
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!